| Name | Title | Contact Details |
|---|
BioPorto s flagship product, The NGAL Test™, aids in the risk assessment of AKI in critically ill patients. CE marked for IVD use in select regions.
Decoding the dark matter of the human genome to uncover novel ways to treat disease Discover More
Sarepta Therapeutics is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA).
Lutonix is a Maple Grove, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.